Die Pharmakonzerne Eli Lilly und Boehringer Ingelheim streichen geplante Investitionen in Deutschland.
Olin and Huntsman, the two major US chemical manufacturers, will create a $12+ billion integrated North American chemicals leader.
A clear signal to Berlin: the pharmaceutical companies Eli Lilly and Boehringer Ingelheim are canceling planned investments in Germany.
Sasol is expanding its Brunsbüttel site with a €60 million investment to boost specialty alumina production and strengthen supply for critical catalyst applications. Operations targeted for 2029.
The digital and intelligent development of the petroleum and chemical industry is a major component of China's 15th five-year plan for chemicals.
Der Essener Chemiekonzern plant den Abbau von etwa 3.200 Stellen und die Einstellung des unrentablen Polyester-Geschäfts.
